medmix AG engages in the business of design and production of delivery devices and applicators for the dental, drug delivery, surgery, industrial, and beauty markets. The firm operates through two reportable segments: Healthcare along with Consumer and Industrial. Healthcare segment includes design and production of high-precision delivery devices and services within drug delivery, surgery and dental markets. Products include injection pens, surgical delivery devices focusing on trauma bone repair and wound healing tissue treatment and mixing, filling and delivery device systems for the dental consumable industry. Consumer and Industrial segment consists of design and production of high precision delivery devices within industry business unit, this includes adhesives used in construction, electronics, automotive, aerospace and various industries, and consumer markets such as beauty and other microbrush applications.
Dr. Rene Willi is the Chief Executive Officer of medmix AG, joining the firm since 2022.
What is the price performance of MEDMIX AG stock?
The current price of MEDMIX AG is $17.4, it has decreased 0% in the last trading day.
What are the primary business themes or industries for medmix AG?
medmix AG belongs to Health Care industry and the sector is Health Care
What is medmix AG market cap?
medmix AG's current market cap is $717.9M
Is medmix AG a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for medmix AG, including 2 strong buy, 5 buy, 1 hold, 0 sell, and 2 strong sell